Abstract
No public abstract is available from the verified source records.
Ayisha Ejaz Bhutta, Zubia Bugti, Rizwana Naz, Mamoona Shuja, Muhammad Shahid Nawaz Khan, Shoaib Liaquat, Amina Shahid
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions
10.1002/ijgo.12666 · 2018
Uterine bleeding: how understanding endometrial physiology underpins menstrual health
10.1038/s41574-021-00629-4 · 2022
Abnormal uterine bleeding
10.1016/j.mcna.2022.10.014 · 2023
Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2
10.1002/ijgo.14946 · 2023
Therapeutic options for the management of abnormal uterine bleeding
10.1002/ijgo.14947 · 2023
Abnormal uterine bleeding in reproductive age women: role of imaging in the diagnosis and management
10.1053/j.sult.2023.10.002 · 2023
Management of women with abnormal uterine bleeding: clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF)
10.1016/j.ejogrb.2023.07.001 · 2023
Therapeutic carbohydrate restriction as a metabolic modality for the prevention and treatment of abnormal uterine bleeding
10.3390/nu15173760 · 2023
Unmet needs in abnormal uterine bleeding due to ovulatory dysfunction
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
10.1080/09513590.2024.2362244 · 2024
Diagnosis of abnormal uterine bleeding based on the FIGO classification: a systematic review and expert opinions
10.1111/jog.16073 · 2024
The uterus is an end organ: a preliminary study of the association between abnormal uterine bleeding and hyperinsulinemia
10.1097/gme.0000000000002548 · 2025
Menstrual irregularities and cardiometabolic risk: a systematic review and meta-analysis
10.1016/j.ejogrb.2025.114796 · 2026
Polycystic ovary syndrome as a metabolic disease
10.1038/s41574-024-01057-w · 2025
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
10.1186/s13048-022-01091-0 · 2023
Hormonal changes in PCOS
10.1530/joe-23-0342 · 2024
The interplay of uterine health and obesity: a comprehensive review
10.3390/biomedicines12122801 · 2024
Female obesity: association with endocrine disruption and reproductive dysfunction
10.1016/j.obmed.2021.100375 · 2021
Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review
10.1016/j.ejogrb.2023.06.028 · 2023
Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2
10.1016/j.biopha.2020.110764 · 2020
Metformin for endometrial hyperplasia
10.1002/14651858.cd012214.pub3 · 2024
No additional external references are available.